slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 28,621-28,650
Pages 10,126
Rows per page 30
Component
28,621-28,650 of 303,780
138
Uses direct quotes from KOLs to undermine the company's product launch narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
139
The slide uses direct quotes from a former executive to undermine management's credibility and the product's market viability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
140
Uses expert testimony to undermine company narrative regarding product success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
141
The slide uses direct quotes from former employees to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
142
Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
143
Uses testimonial-style quotes from a competitor's regional sales manager to undermine the target company's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
144
Uses quotes from KOLs and former users to frame the company as a 'one-trick pony' facing inevitable decline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
145
The slide uses expert quotes to frame the company's strategic pivot as a sign of desperation and loss of identity.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
146
Uses yellow highlighting to emphasize key claims of deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
147
Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
148
Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
149
Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
150
Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
151
Uses expert quotes to undermine the company's core product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
152
Uses KOL testimonials to highlight a technical contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
154
Uses direct quotes from KOLs to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
155
The slide uses a 'quote-heavy' structure to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
157
Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
158
Uses a series of quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
160
Uses expert testimony (KOLs) to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
161
The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
162
The slide uses expert testimony to undermine the credibility of the company's clinical research and growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
163
Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
166
The slide uses direct quotes from KOLs and former executives to undermine the credibility of Nevro's clinical trials.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
167
Uses multiple KOL quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
169
Uses expert testimony (KOLs and former executives) to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
170
The slide uses a 'quote-sandwich' structure to validate the thesis headline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
171
Uses expert testimony to contradict company growth narratives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits